UBS analyst AJ Rice upgraded Enhabit (EHAB) to Buy from Neutral with a price target of $12, up from $8.50. The firm believes the the final home health rule provides more clarity around Enhabit’s future earnings outlook. The firm cites this and the stock’s “discounted valuation” for the upgrade.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHAB: